Comparison of efficacy Cinnal-F and Gonal-F on infertility treatment(ICSI)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015110313907N2

Enrollment

142

Registered

2016-05-15

Start date

2014-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

In this study,the patients were prescribed OCP in previous mense and according to the kind of stimulation protocol (long ,short, antagonist) in further menstrual cycle the physicians were prescribed f

Treatment - Drugs

Eligibility

Sex/Gender

Female

Age

18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: FSH 30; histort of severe OHSS; Hx. of poor response in previous cycles; any pathology in uterus and anenexae.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of MII oocytes. Timepoint: During ovum pick up. Method of measurement: By observing under electron microscopy by embryologist.	—

Secondary

Measure	Time frame
Number of grade A embryos. Timepoint: after 3 days of development at laboratory. Method of measurement: Observing by embryologist under electron microscopy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Arjmand Teymouri

Avicenna Infertility Clinic

f.arjmand@avicenna.ac.ir+98 21 23519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026